Profit Surge and Capital Strength Fail to Halt Munich Re’s Share Price Slide

Despite a 57% profit jump and strong capital, Munich Re shares hit 52-week low as investors focus on shrinking reinsurance premiums and a challenging revenue target.

A surge in quarterly earnings and a rock-solid capital position have done nothing to stop Munich Re’s shares from plumbing new lows, as investors fixate on a shrinking top line in the reinsurer’s core business. The disconnect between robust operational metrics and the stock’s trajectory has rarely been starker.

Net profit for the first quarter of 2026 jumped roughly 57% to €1.714bn, propelled by a sharp drop in large-loss charges. The prior-year period was weighed down by more than €1bn in claims from the Los Angeles wildfires; this year, catastrophe losses came in at just €130m. The annualised return on equity hit 19.7%, well above the long-term target in the group’s “Ambition 2030” strategy.

Yet the shares slid to a 52-week low of €464.30 on Thursday, bringing the 30-day decline to more than 17%. The stock’s year-to-date loss stands at 14.88%, with the recent close at €467.30 far from offering any support. A €2.25bn share buyback launched in April has so far failed to stem the selling pressure.

The root of the unease lies in the reinsurance division, where premium income fell from €15.8bn to roughly €15bn year-on-year. Management attributes the drop to negative currency effects worth €162m and price adjustments. Finance chief Andrew Buchanan now describes the original goal of €40bn in full-year reinsurance revenue as “challenging”, stressing that profitability must take precedence over volume growth.

The group’s capital position remains exceptionally strong. The solvency ratio stood at 292% at the end of March, well above the 200% lower end of the internal target range, even after accounting for the planned dividend and the new buyback. That buffer gives Munich Re ample room to absorb large natural catastrophes or market volatility.

Below the surface, other segments showed resilience. Primary insurance subsidiary ERGO contributed a net result of €235m, driven by short-term travel and health policies in Germany, while its international business added €78m, on track for the year. In life and health reinsurance, the technical result reached €500m, slightly ahead of the pro-rata annual path.

Investment income added further ballast. The portfolio generated €1.68bn in the quarter, with a current yield of 3.5% and a reinvestment rate of 4.2%. Positive revaluations in commodities and alternative assets helped offset fixed-income volatility.

The company’s pricing discipline is evident in the April renewal season, where Munich Re cut its exposure in Asian markets by 18.5%, walking away from Japanese and Indian business rather than accepting unattractive terms. One area of expansion remains cyber insurance, where the group sees the global market at roughly $15bn, driven by rising awareness among small and midsize enterprises.

Management has confirmed the full-year net profit target of €6.3bn, contingent on large-loss activity remaining benign. The share price, however, continues to reflect concerns about volume contraction rather than the strength of the balance sheet. Unless the core reinsurance franchise delivers clearer revenue momentum, Munich Re’s deep capital moat may not be enough to turn the tide.